Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Stenzel, C; Dalkner, N; Unterrainer, HF; Birner, A; Bengesser, SA; Fellendorf, FT; Fink, A; Fleischmann, E; Lenger, M; Maget, A; Platzer, M; Queissner, R; Schönthaler, E; Tmava-Berisha, A; Reininghaus, EZ.
Effects of metabolic syndrome and obesity on suicidality in individuals with bipolar disorder.
J Affect Disord. 2022; 311:1-7 Doi: 10.1016/j.jad.2022.05.062
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Dalkner Nina
Co-Autor*innen der Med Uni Graz
Bengesser Susanne
Birner Armin
Fellendorf Frederike
Fleischmann Eva
Lenger Melanie
Maget Alexander
Platzer Martina
Queissner Robert
Reininghaus Eva
Schönthaler Elena
Tmava-Berisha Adelina
Unterrainer Human-Friedrich

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

BACKGROUND: The prevalence of metabolic syndrome and overweight/obesity is increased in bipolar disorder (BD) compared to the general population and is related to suicidality. The aim of this study was to examine the association between both the rate of suicidal ideation and suicide attempts and metabolic variables in individuals with BD. METHODS: Anthropometric measures, socio-demographic data, suicide history and serum lipid levels were measured in 215 individuals with BD. Individuals were divided into normal weight, overweight and obese according to their body mass index (BMI), and metabolic syndrome was assessed using "The International Diabetes Federation"-criteria. RESULTS: Of the 215 individuals studied, 80.9% reported suicidal ideation, 35.3% reported at least one suicide attempt and 30.7% were diagnosed with metabolic syndrome. Both metabolic syndrome and BMI were not related to suicide attempts. However, individuals with normal weight had more suicidal ideation than overweight individuals, while obese individuals did not differ from either group. Furthermore, there was no association between suicide attempts or suicidal ideation and serum lipid levels. LIMITATIONS: The cross-sectional design of the study, a non-standardized questionnaire for suicidality, and not controlling the medication intake are limiting factors. CONCLUSION: Contrary to expectations, a difference was found in the BMI categories and suicidal ideation, but not suicide attempts. Serum lipid levels were found to be unsuitable as possible biomarkers for suicidality in individuals with BD. Special attention should be paid to suicidal ideation and BMI rather than metabolic syndrome or lipid values when treating suicidal individuals with BD.
Find related publications in this database (using NLM MeSH Indexing)
Bipolar Disorder - epidemiology
Cross-Sectional Studies - administration & dosage
Humans - administration & dosage
Lipids - administration & dosage
Metabolic Syndrome - epidemiology
Obesity - epidemiology
Overweight - epidemiology
Risk Factors - administration & dosage
Suicidal Ideation - administration & dosage
Suicide - administration & dosage

Find related publications in this database (Keywords)
Bipolar disorder
Metabolic syndrome
Lipid markers
© Med Uni Graz Impressum